5Castellano G, Affuso F, Di Conza P, et al. Myocarditis and dilated cardiomyopathy: possible connections and treatments [J]. J Cardiovasc Med, 2008, 9(7) : 666-671.
6Daniels MD, Hyland KV, Wang K, et al. Recombinant car- diac myosin fragment induces experimental autoimmune my- ocarditis via activation of Thl and Thl7 immunity[J]. Au- toimmunity, 2008, 41(6): 490-499.
7Youinou P, Jamin C. The weight of interleukin-6 in B cell- related autoimmune disorders [ J ] . J Autoinumun , 2009, 32 (3-4) : 206-210.
8Frey N, Grange S, Woodworth T. Population pharmacokinet-ic analysis of tocilizumab in patients with rheumatoid arthritis [J]. J Clin Pharmacol, 2010, 50(7) : 754-766.
9Baldeviano GC, Barin JG, Talor MV, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression todilated cardiomyopathy[J]. Circ Res, 2010, 106( 10): 1646-1655.
10Haudek SB, Trim J, Xia Y, et al. Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells [J]. Proc Nail Acad Sci USA, 2008, 105(29): 10179- 10184.
